VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia
NCT00291187
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
411
Enrollment
INDUSTRY
Sponsor class
Conditions
Insomnia
Interventions
DRUG:
20 mg VEC-162
DRUG:
50 mg VEC-162
DRUG:
100 mg VEC-162
DRUG:
Placebo
Sponsor
Vanda Pharmaceuticals